APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Zoster Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Zoster Vaccine Market Analysis and Forecast 2026-2032

Report ID 174048950220 December 2025196 pages

Choose your research edition.

Industry ResearchZoster Vaccine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Zoster Vaccine Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Zoster Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Zoster Vaccine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Zoster Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Zoster Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Zoster Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Zoster Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Zoster Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Zoster Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Zoster Vaccine include GSK, Merck, SK chemicals, Sanofi Pasteur and Green Cross Corp, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Zoster Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Zoster Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Zoster Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Zoster Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Zoster Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Zoster Vaccine sales, projected growth trends, production technology, application and end-user industry.

Zoster Vaccine Segment by Company

GSK

Merck

SK chemicals

Sanofi Pasteur

Green Cross Corp

Zoster Vaccine Segment by Type

Live Attenuated Vaccine

Recombinant

Zoster Vaccine Segment by Application

Government Institution

Private Sector

Other

Zoster Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zoster Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Zoster Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zoster Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Zoster Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Zoster Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Zoster Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Zoster Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Live Attenuated Vaccine Major Manufacturers Table 3. Recombinant Major Manufacturers Table 4. Global Zoster Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Government Institution Major Manufacturers Table 6. Private Sector Major Manufacturers Table 7. Other Major Manufacturers Table 8. Zoster Vaccine Industry Trends Table 9. Zoster Vaccine Industry Drivers Table 10. Zoster Vaccine Industry Opportunities and Challenges Table 11. Zoster Vaccine Industry Restraints Table 12. Global Zoster Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Zoster Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Zoster Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Zoster Vaccine Revenue Market Share by Region (2021-2026) Table 16. Global Zoster Vaccine Revenue Market Share by Region (2027-2032) Table 17. Global Zoster Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 18. Global Zoster Vaccine Sales by Region (2021-2026) & (W Units) Table 19. Global Zoster Vaccine Sales by Region (2027-2032) & (W Units) Table 20. Global Zoster Vaccine Sales Market Share by Region (2021-2026) Table 21. Global Zoster Vaccine Sales Market Share by Region (2027-2032) Table 22. Global Zoster Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Zoster Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Zoster Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Zoster Vaccine Sales Market Share by Manufacturers (2021-2026) Table 26. Global Zoster Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Zoster Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Zoster Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Zoster Vaccine Manufacturers, Product Type & Application Table 30. Global Zoster Vaccine Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Zoster Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Zoster Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Zoster Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Zoster Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Zoster Vaccine Revenue Market Share by Type (2021-2026) Table 37. Global Zoster Vaccine Revenue Market Share by Type (2027-2032) Table 38. Global Zoster Vaccine Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 39. Global Zoster Vaccine Sales by Type (2021-2026) & (W Units) Table 40. Global Zoster Vaccine Sales by Type (2027-2032) & (W Units) Table 41. Global Zoster Vaccine Sales Market Share by Type (2021-2026) Table 42. Global Zoster Vaccine Sales Market Share by Type (2027-2032) Table 43. Global Zoster Vaccine Price by Type (2021-2026) & (US$/Unit) Table 44. Global Zoster Vaccine Price by Type (2027-2032) & (US$/Unit) Table 45. Global Zoster Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Zoster Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Zoster Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Zoster Vaccine Revenue Market Share by Application (2021-2026) Table 49. Global Zoster Vaccine Revenue Market Share by Application (2027-2032) Table 50. Global Zoster Vaccine Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 51. Global Zoster Vaccine Sales by Application (2021-2026) & (W Units) Table 52. Global Zoster Vaccine Sales by Application (2027-2032) & (W Units) Table 53. Global Zoster Vaccine Sales Market Share by Application (2021-2026) Table 54. Global Zoster Vaccine Sales Market Share by Application (2027-2032) Table 55. Global Zoster Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Zoster Vaccine Price by Application (2027-2032) & (US$/Unit) Table 57. GSK Company Information Table 58. GSK Business Overview Table 59. GSK Zoster Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. GSK Zoster Vaccine Product Portfolio Table 61. GSK Recent Development Table 62. Merck Company Information Table 63. Merck Business Overview Table 64. Merck Zoster Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Merck Zoster Vaccine Product Portfolio Table 66. Merck Recent Development Table 67. SK chemicals Company Information Table 68. SK chemicals Business Overview Table 69. SK chemicals Zoster Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. SK chemicals Zoster Vaccine Product Portfolio Table 71. SK chemicals Recent Development Table 72. Sanofi Pasteur Company Information Table 73. Sanofi Pasteur Business Overview Table 74. Sanofi Pasteur Zoster Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sanofi Pasteur Zoster Vaccine Product Portfolio Table 76. Sanofi Pasteur Recent Development Table 77. Green Cross Corp Company Information Table 78. Green Cross Corp Business Overview Table 79. Green Cross Corp Zoster Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Green Cross Corp Zoster Vaccine Product Portfolio Table 81. Green Cross Corp Recent Development Table 82. North America Zoster Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Zoster Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Zoster Vaccine Sales by Type (2021-2026) & (W Units) Table 85. North America Zoster Vaccine Sales by Type (2027-2032) & (W Units) Table 86. North America Zoster Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 87. North America Zoster Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 88. North America Zoster Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Zoster Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Zoster Vaccine Sales by Application (2021-2026) & (W Units) Table 91. North America Zoster Vaccine Sales by Application (2027-2032) & (W Units) Table 92. North America Zoster Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 93. North America Zoster Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 94. North America Zoster Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Zoster Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 96. North America Zoster Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 97. North America Zoster Vaccine Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 98. North America Zoster Vaccine Sales by Country (2021-2026) & (W Units) Table 99. North America Zoster Vaccine Sales by Country (2027-2032) & (W Units) Table 100. North America Zoster Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 101. North America Zoster Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 102. United States Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 103. Canada Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 104. Europe Zoster Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 105. Europe Zoster Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 106. Europe Zoster Vaccine Sales by Type (2021-2026) & (W Units) Table 107. Europe Zoster Vaccine Sales by Type (2027-2032) & (W Units) Table 108. Europe Zoster Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 109. Europe Zoster Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 110. Europe Zoster Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Zoster Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Zoster Vaccine Sales by Application (2021-2026) & (W Units) Table 113. Europe Zoster Vaccine Sales by Application (2027-2032) & (W Units) Table 114. Europe Zoster Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 115. Europe Zoster Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 116. Europe Zoster Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Zoster Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. Europe Zoster Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. Europe Zoster Vaccine Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 120. Europe Zoster Vaccine Sales by Country (2021-2026) & (W Units) Table 121. Europe Zoster Vaccine Sales by Country (2027-2032) & (W Units) Table 122. Europe Zoster Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 123. Europe Zoster Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 124. Germany Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 125. France Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 126. U.K. Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 127. Italy Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 128. Netherlands Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 129. China Zoster Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 130. China Zoster Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 131. China Zoster Vaccine Sales by Type (2021-2026) & (W Units) Table 132. China Zoster Vaccine Sales by Type (2027-2032) & (W Units) Table 133. China Zoster Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 134. China Zoster Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 135. China Zoster Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 136. China Zoster Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 137. China Zoster Vaccine Sales by Application (2021-2026) & (W Units) Table 138. China Zoster Vaccine Sales by Application (2027-2032) & (W Units) Table 139. China Zoster Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 140. China Zoster Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 141. Asia Zoster Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 142. Asia Zoster Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 143. Asia Zoster Vaccine Sales by Type (2021-2026) & (W Units) Table 144. Asia Zoster Vaccine Sales by Type (2027-2032) & (W Units) Table 145. Asia Zoster Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 146. Asia Zoster Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 147. Asia Zoster Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 148. Asia Zoster Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 149. Asia Zoster Vaccine Sales by Application (2021-2026) & (W Units) Table 150. Asia Zoster Vaccine Sales by Application (2027-2032) & (W Units) Table 151. Asia Zoster Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 152. Asia Zoster Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 153. Asia Zoster Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Asia Zoster Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. Asia Zoster Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. Asia Zoster Vaccine Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 157. Asia Zoster Vaccine Sales by Country (2021-2026) & (W Units) Table 158. Asia Zoster Vaccine Sales by Country (2027-2032) & (W Units) Table 159. Asia Zoster Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 160. Asia Zoster Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 161. Japan Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 162. South Korea Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 163. India Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 164. Australia Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 165. China Taiwan Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 166. Southeast Asia Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 167. SAMEA Zoster Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 168. SAMEA Zoster Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 169. SAMEA Zoster Vaccine Sales by Type (2021-2026) & (W Units) Table 170. SAMEA Zoster Vaccine Sales by Type (2027-2032) & (W Units) Table 171. SAMEA Zoster Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 172. SAMEA Zoster Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 173. SAMEA Zoster Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 174. SAMEA Zoster Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 175. SAMEA Zoster Vaccine Sales by Application (2021-2026) & (W Units) Table 176. SAMEA Zoster Vaccine Sales by Application (2027-2032) & (W Units) Table 177. SAMEA Zoster Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 178. SAMEA Zoster Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 179. SAMEA Zoster Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. SAMEA Zoster Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. SAMEA Zoster Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. SAMEA Zoster Vaccine Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 183. SAMEA Zoster Vaccine Sales by Country (2021-2026) & (W Units) Table 184. SAMEA Zoster Vaccine Sales by Country (2027-2032) & (W Units) Table 185. SAMEA Zoster Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 186. SAMEA Zoster Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 187. Brazil Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 188. Argentina Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 189. Chile Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 190. Colombia Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 191. Peru Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 192. Saudi Arabia Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 193. Israel Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 194. UAE Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 195. Turkey Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 196. Iran Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 197. Egypt Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 198. Key Raw Materials Table 199. Raw Materials Key Suppliers Table 200. Zoster Vaccine Distributors List Table 201. Zoster Vaccine Customers List Table 202. Research Programs/Design for This Report Table 203. Authors List of This Report Table 204. Secondary Sources Table 205. Primary Sources List of Figures Figure 1. Zoster Vaccine Image Figure 2. Global Zoster Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Zoster Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Live Attenuated Vaccine Image Figure 5. Recombinant Image Figure 6. Global Zoster Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Zoster Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Government Institution Image Figure 9. Private Sector Image Figure 10. Other Image Figure 11. Global Zoster Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Zoster Vaccine Revenue (2021-2032) & (US$ Million) Figure 13. Global Zoster Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Zoster Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Zoster Vaccine Revenue Market Share by Region (2021-2032) Figure 16. Global Zoster Vaccine Sales (2021-2032) & (W Units) Figure 17. Global Zoster Vaccine Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 18. Global Zoster Vaccine Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Zoster Vaccine Sales YoY (2021-2032) & (W Units) Figure 20. Europe Zoster Vaccine Sales YoY (2021-2032) & (W Units) Figure 21. China Zoster Vaccine Sales YoY (2021-2032) & (W Units) Figure 22. Asia (Excluding China) Zoster Vaccine Sales YoY (2021-2032) & (W Units) Figure 23. South America, Middle East and Africa Zoster Vaccine Sales YoY (2021-2032) & (W Units) Figure 24. Global Zoster Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Zoster Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Zoster Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Zoster Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Zoster Vaccine Revenue Market Share by Type (2021-2032) Figure 30. Global Zoster Vaccine Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 31. Global Zoster Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Zoster Vaccine Sales Market Share by Type (2021-2032) Figure 33. Global Zoster Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Zoster Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Zoster Vaccine Revenue Market Share by Application (2021-2032) Figure 36. Global Zoster Vaccine Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 37. Global Zoster Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Zoster Vaccine Sales Market Share by Application (2021-2032) Figure 39. North America Zoster Vaccine Revenue Share by Type (2021-2032) Figure 40. North America Zoster Vaccine Sales Share by Type (2021-2032) Figure 41. North America Zoster Vaccine Revenue Share by Application (2021-2032) Figure 42. North America Zoster Vaccine Sales Share by Application (2021-2032) Figure 43. North America Zoster Vaccine Revenue Share by Country (2021-2032) Figure 44. North America Zoster Vaccine Sales Share by Country (2021-2032) Figure 45. Europe Zoster Vaccine Revenue Share by Type (2021-2032) Figure 46. Europe Zoster Vaccine Sales Share by Type (2021-2032) Figure 47. Europe Zoster Vaccine Revenue Share by Application (2021-2032) Figure 48. Europe Zoster Vaccine Sales Share by Application (2021-2032) Figure 49. Europe Zoster Vaccine Revenue Share by Country (2021-2032) Figure 50. Europe Zoster Vaccine Sales Share by Country (2021-2032) Figure 51. China Zoster Vaccine Revenue Share by Type (2021-2032) Figure 52. China Zoster Vaccine Sales Share by Type (2021-2032) Figure 53. China Zoster Vaccine Revenue Share by Application (2021-2032) Figure 54. China Zoster Vaccine Sales Share by Application (2021-2032) Figure 55. Asia Zoster Vaccine Revenue Share by Type (2021-2032) Figure 56. Asia Zoster Vaccine Sales Share by Type (2021-2032) Figure 57. Asia Zoster Vaccine Revenue Share by Application (2021-2032) Figure 58. Asia Zoster Vaccine Sales Share by Application (2021-2032) Figure 59. Asia Zoster Vaccine Revenue Share by Country (2021-2032) Figure 60. Asia Zoster Vaccine Sales Share by Country (2021-2032) Figure 61. SAMEA Zoster Vaccine Revenue Share by Type (2021-2032) Figure 62. SAMEA Zoster Vaccine Sales Share by Type (2021-2032) Figure 63. SAMEA Zoster Vaccine Revenue Share by Application (2021-2032) Figure 64. SAMEA Zoster Vaccine Sales Share by Application (2021-2032) Figure 65. SAMEA Zoster Vaccine Revenue Share by Country (2021-2032) Figure 66. SAMEA Zoster Vaccine Sales Share by Country (2021-2032) Figure 67. Zoster Vaccine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Zoster Vaccine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Live Attenuated Vaccine
  • Recombinant
Applications
  • Government Institution
  • Private Sector
  • Other
Companies covered
  • GSK
  • Merck
  • SK chemicals
  • Sanofi Pasteur
  • Green Cross Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Zoster Vaccine Market by Type
  3. 1.2.1 Global Zoster Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Live Attenuated Vaccine
  5. 1.2.3 Recombinant
  6. 1.3 Zoster Vaccine Market by Application
  7. 1.3.1 Global Zoster Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Government Institution
  9. 1.3.3 Private Sector
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Zoster Vaccine Market Dynamics
  1. 2.1 Zoster Vaccine Industry Trends
  2. 2.2 Zoster Vaccine Industry Drivers
  3. 2.3 Zoster Vaccine Industry Opportunities and Challenges
  4. 2.4 Zoster Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Zoster Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Zoster Vaccine Revenue by Region
  3. 3.2.1 Global Zoster Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Zoster Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Zoster Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Zoster Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Zoster Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Zoster Vaccine Sales by Region
  9. 3.4.1 Global Zoster Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Zoster Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Zoster Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Zoster Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Zoster Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Zoster Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Zoster Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Zoster Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Zoster Vaccine Sales by Manufacturers
  6. 4.2.1 Global Zoster Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Zoster Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Zoster Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Zoster Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Zoster Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Zoster Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Zoster Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Zoster Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Zoster Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Zoster Vaccine Tier 1, Tier 2, and Tier 3
5 Zoster Vaccine Market by Type
  1. 5.1 Global Zoster Vaccine Revenue by Type
  2. 5.1.1 Global Zoster Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Zoster Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Zoster Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Zoster Vaccine Sales by Type
  6. 5.2.1 Global Zoster Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Zoster Vaccine Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Zoster Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Zoster Vaccine Price by Type
6 Zoster Vaccine Market by Application
  1. 6.1 Global Zoster Vaccine Revenue by Application
  2. 6.1.1 Global Zoster Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Zoster Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Zoster Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Zoster Vaccine Sales by Application
  6. 6.2.1 Global Zoster Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Zoster Vaccine Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Zoster Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Zoster Vaccine Price by Application
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Zoster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GSK Zoster Vaccine Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Zoster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Zoster Vaccine Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 SK chemicals
  14. 7.3.1 SK chemicals Company Information
  15. 7.3.2 SK chemicals Business Overview
  16. 7.3.3 SK chemicals Zoster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 SK chemicals Zoster Vaccine Product Portfolio
  18. 7.3.5 SK chemicals Recent Developments
  19. 7.4 Sanofi Pasteur
  20. 7.4.1 Sanofi Pasteur Company Information
  21. 7.4.2 Sanofi Pasteur Business Overview
  22. 7.4.3 Sanofi Pasteur Zoster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sanofi Pasteur Zoster Vaccine Product Portfolio
  24. 7.4.5 Sanofi Pasteur Recent Developments
  25. 7.5 Green Cross Corp
  26. 7.5.1 Green Cross Corp Company Information
  27. 7.5.2 Green Cross Corp Business Overview
  28. 7.5.3 Green Cross Corp Zoster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Green Cross Corp Zoster Vaccine Product Portfolio
  30. 7.5.5 Green Cross Corp Recent Developments
8 North America
  1. 8.1 North America Zoster Vaccine Market Size by Type
  2. 8.1.1 North America Zoster Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Zoster Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Zoster Vaccine Price by Type (2021-2032)
  5. 8.2 North America Zoster Vaccine Market Size by Application
  6. 8.2.1 North America Zoster Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Zoster Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Zoster Vaccine Price by Application (2021-2032)
  9. 8.3 North America Zoster Vaccine Market Size by Country
  10. 8.3.1 North America Zoster Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Zoster Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Zoster Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Zoster Vaccine Market Size by Type
  2. 9.1.1 Europe Zoster Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Zoster Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Zoster Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Zoster Vaccine Market Size by Application
  6. 9.2.1 Europe Zoster Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Zoster Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Zoster Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Zoster Vaccine Market Size by Country
  10. 9.3.1 Europe Zoster Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Zoster Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Zoster Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Zoster Vaccine Market Size by Type
  2. 10.1.1 China Zoster Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Zoster Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Zoster Vaccine Price by Type (2021-2032)
  5. 10.2 China Zoster Vaccine Market Size by Application
  6. 10.2.1 China Zoster Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Zoster Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Zoster Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Zoster Vaccine Market Size by Type
  2. 11.1.1 Asia Zoster Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Zoster Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Zoster Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Zoster Vaccine Market Size by Application
  6. 11.2.1 Asia Zoster Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Zoster Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Zoster Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Zoster Vaccine Market Size by Country
  10. 11.3.1 Asia Zoster Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Zoster Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Zoster Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Zoster Vaccine Market Size by Type
  2. 12.1.1 SAMEA Zoster Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Zoster Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Zoster Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Zoster Vaccine Market Size by Application
  6. 12.2.1 SAMEA Zoster Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Zoster Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Zoster Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Zoster Vaccine Market Size by Country
  10. 12.3.1 SAMEA Zoster Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Zoster Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Zoster Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Zoster Vaccine Value Chain Analysis
  2. 13.1.1 Zoster Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Zoster Vaccine Production Mode & Process
  6. 13.2 Zoster Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Zoster Vaccine Distributors
  9. 13.2.3 Zoster Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst